ライフサイエンスコーパス: cervix

1 t of placebo (fibroid protruding through the cervix).

2 ular mechanisms that govern PG action in the cervix.

3 ntly infected animals inoculated only in the cervix.

4 cervical squamocolumnar (SC) junction of the cervix.

5 ines as well as in carcinomas of the uterine cervix.

6 found in more than 70% of carcinomas of the cervix.

7 type 16 (HPV16), cause cancer of the uterine cervix.

8 single-shot DW echo-planar MR imaging of the cervix.

9 lva, vagina, urethra, ovary, and the uterine cervix.

10 )Cu-ATSM in women with cancer of the uterine cervix.

11 ident oncogenic HPV infection of the uterine cervix.

12 integrated HPV-16 DNA compared to the normal cervix.

13 16 DNA compared to both C-33A and the normal cervix.

14 s and precancerous conditions of the uterine cervix.

15 s for locally advanced cancer of the uterine cervix.

16 review of 152 patients with carcinoma of the cervix.

17 ent and acute visceral pain from the uterine cervix.

18 for benign disease and they no longer have a cervix.

19 or recurrent squamous cell carcinoma of the cervix.

20 ions and advanced squamous carcinomas of the cervix.

21 n papillomavirus oncogenesis of the skin and cervix.

22 m birth in patients with a short sonographic cervix.

23 nts proved to have invasive carcinoma of the cervix.

24 (28.8%) were found to have carcinoma of the cervix.

25 rongly associated with adenocarcinoma of the cervix.

26 or persistent squamous cell carcinoma of the cervix.

27 ssible survival in squamous carcinoma of the cervix.

28 squamous epithelium and reserve cells of the cervix.

29 ancreas, kidney, urinary bladder and uterine cervix.

30 arrested progress at full dilatation of the cervix.

31 hose of CT in patients with carcinoma of the cervix.

32 have had a hysterectomy with removal of the cervix.

33 ted women was calculated and compared to the cervix.

34 d, persistent, or recurrent carcinoma of the cervix.

35 lium, normally found near the more posterior cervix.

36 8(+) T cells, was detected in 4.8% of normal cervix, 0% of HIV-negative high-grade dysplasia, and 40%

37 0.0001), kidney (1.25, 1.17-1.33; p<0.0001), cervix (1.10, 1.03-1.17; p=0.00035), thyroid (1.09, 1.00

38 DNA in cervical tissue specimens with normal cervix (20 cases), cervical intraepithelial neoplasia (C

39 ositivity was less common for cancers of the cervix (3.3%), vagina (8.3%), vulva (1.5%), and penis (8

40 n-Hodgkin lymphoma [11.51, 11.14-11.89], and cervix [3.24, 2.94-3.56]), most other virus-related canc

41 estrous cycle during viral infection of the cervix; (3) after kidney infection, the number of infect

42 minal centers were present in 4.7% of normal cervix, 33% of high-grade lesions from HIV-negative wome

43 80%; Hodgkin disease, 50% and more than 90%; cervix, 40% and 70%-80%; uterus (endometrium), 80% and m

44 interval [CI], 4.9%-79.1%) was comparable to cervix (45.8%; 95% CI, 6.4%-69.4%).

45 both the anal canal (13.2% of women) and the cervix (5.1%).

46 oid follicles were present in 9.5% of normal cervix, 57% of HIV-negative high-grade dysplasia, and 50

47 (62.0%, 95% CI 47.1-73.1) compared with the cervix (76.4%, 67.0-83.5; p for interaction by anatomica

48 n with singleton pregnancies who had a short cervix, a cervical pessary did not result in a lower rat

49 of the lungs, head and neck, oesophagus, and cervix account for up to 30% of cancer deaths, the mecha

50 confirm the absence of residual tumor in the cervix after a cone biopsy with negative margins.

51 e second most frequent cancer of the uterine cervix after squamous carcinoma, and the most frequent h

52 (HPV) infection among women was 42.7% in the cervix and 3.8% in the oral cavity.

53 ents of human cancers including those of the cervix and also of the head and neck; HPV16 is the most

54 se phenotypes (M1 and M2) are present in the cervix and are most likely involved in the postpartum re

55 as digital and ultrasound evaluations of the cervix and assays for fetal fibronectin in cervicovagina

56 detection of monotypic sequences across the cervix and blood, especially during effective ART, sugge

57 However HIV-1 levels within the cervix and breast milk were not associated with CMV with

58 d CD4 counts were associated with CMV in the cervix and breast milk.

59 Of 166 miRNAs expressed in normal cervix and cancer cell lines, we observed significant ex

60 noncontiguous cervical biopsies or from the cervix and circulating PBMC in seven of eight subjects.

61 vical infection model in which we bypass the cervix and directly inoculate C. trachomatis into the ut

62 allopian tubes and endometrium), followed by cervix and ectocervix.

63 ding fallopian tube, gastrointestinal tract, cervix and endometriosis.

64 nd angiogenesis in advanced carcinoma of the cervix and examining the levels of angiogenic proteins m

65 mited to patients with cancer of the uterine cervix and for patients with ovarian cancer.

66 We used Policy1-Cervix and HPV-ADVISE-two dynamic models of HPV transmis

67 with M. genitalium strain G37 in the uterine cervix and in salpingeal pockets generated by transplant

68 ests (NAAT) for Chlamydia trachomatis at the cervix and in urine was examined in 3,551 women, and the

69 risk factors for vulvar HPV were similar to cervix and included: age (adjusted odds ratio [aOR] 0.5

70 iruses homing to and/or expanding within the cervix and is rarely due to unique viruses evolving with

71 n, and this pain originates from the uterine cervix and is transmitted via the hypogastric nerve to t

72 dules for the ovary, fallopian tube, uterus, cervix and liver, with a sustained circulating flow betw

73 P expression is very low or absent in normal cervix and LSILs, is readily detectable in HSILs, and is

74 st, head and neck, colon, prostate, bladder, cervix and lung, and has been related to disease progres

75 ation of multipotential reserve cells in the cervix and may be operative in other epithelial stromal

76 e naturally deposited at the entrance to the cervix and must swim through viscoelastic cervical mucus

77 n average 3 and 8 years before diagnosis for cervix and noncervix cancers, respectively) and 718 matc

78 development of squamous cell cancers of the cervix and of the head and neck.

79 be repressed in HPV-positive cancers of the cervix and oropharynx is miR-424.

80 enic types of HPV (HPV 16 and HPV 18) at the cervix and other anatomical sites at which HPV-related c

81 (HPVs) are associated with carcinomas of the cervix and other genital tumors.

82 The rate of new HPV detection at the cervix and penis were 33.83 events/1000 person-months (9

83 t details unique mechanisms of action in the cervix and serves as a catalyst for (i) the use of 15-PG

84 in dysplasias and squamous carcinomas of the cervix and skin.

85 pression of CD40 in epithelial tumors of the cervix and support the clinical exploitation of the CD40

86 t MR imaging of the subglandular and stromal cervix and the difference between both were correlated t

87 rs for in vivo detection of dysplasia in the cervix and the esophagus.

88 butions of HPV genotypes were similar in the cervix and the urine for the majority of types examined.

89 cancer and its precursor lesions in both the cervix and the vagina.

90 of mammals, including the oviducts, uterus, cervix and upper vagina, are derived from the Mullerian

91 and increased leukocyte infiltration in the cervix and uterus compared to AZ2.

92 en, and of applying antiseptic washes to the cervix and vagina during labor, are in progress.

93 Specifically, HA depletion in the cervix and vagina resulted in inappropriate differentiat

94 in the female lower reproductive tracts (ie, cervix and vagina) in the human papillomavirus transgeni

95 inflammatory responses to infection in both cervix and vagina, recruits CD4(+) T cells to fuel this

96 urine and those in cellular sampling of the cervix and vulva, and their correlation with rigorously

97 have had a hysterectomy with removal of the cervix and who do not have a history of a high-grade pre

98 n cancers of the ovary, lung, head and neck, cervix, and BRCA1 positive and basal breast cancers.

99 imarily as a nuclear protein in skin, normal cervix, and cervical cancer tissues, but not in larynx.

100 single neurons to stimulation of the uterus, cervix, and colon were more likely to be excitatory (ver

101 rushing of hindquarter skin, pressure on the cervix, and distention of the uterus, vagina, or colon.

102 ved in fallopian tubes, uterine endometrium, cervix, and ectocervix.

103 colon and rectum, stomach, prostate, liver, cervix, and esophagus-the most important risk factors, c

104 ther surface epithelia, including epidermis, cervix, and esophagus.

105 nancies, especially cancers of the GI tract, cervix, and head and neck.

106 ined nitric oxide (NO) concentrations in the cervix, and high NO levels are related to carcinogenesis

107 performances were similar for LCR-urine, LCR-cervix, and LCR-ThinPrep, with sensitivities from 93 to

108 Cancers of the breast, uterine cervix, and lip or oral cavity are three of the most com

109 me, poor knowledge about the location of the cervix, and not knowing that a vaccine could prevent cer

110 or death from cancers of the breast, uterus, cervix, and ovary in women.

111 ins, including colon, breast, lung, stomach, cervix, and ovary, and demonstrate DNA hypermethylation

112 re able to control HPV-16 replication at the cervix, and reactivation, if it occurs, is not very comm

113 n self-renewing epithelium of the intestine, cervix, and skin.

114 imary human keratinocytes from the foreskin, cervix, and tonsils.

115 ew cell populations in the breast, prostate, cervix, and upper reproductive tract-are shared by embry

116 ithelial cell differentiation in the vagina, cervix, and urinary tract.

117 etrium, as well as epithelia of the oviduct, cervix, and vagina.

118 Compartmentalization of viruses within the cervix appears in part due to viruses homing to and/or e

119 ost frequently associated with cancer of the cervix are now available.

120 chanisms of this paradoxical function of the cervix are unknown.

121 activated organisms were inoculated into the cervix at any time interval.

122 Among the biochemical changes in the cervix at parturition is a marked increase in the hyalur

123 Leukocytes infiltrate the cervix before and after birth and are proposed to regula

124 e monocytes and eosinophils increased in the cervix before birth in a progesterone-regulated fashion,

125 ng on the incidence of adenocarcinoma of the cervix between 1971 and 1992.

126 s- and gain-of-function experiments in human cervix, breast, and pancreatic cancer cells.

127 es localized inflammation of the urethra and cervix by inducing production of IL-1beta and other infl

128 cyte and cytokine environment induced in the cervix by seminal fluid appears competent to initiate ad

129 nvolved in the pathogenesis of cancer of the cervix (CaCx).

130 p in advanced stage carcinoma of the uterine cervix (CaCx).

131 reported that VHR is upregulated in several cervix cancer cell lines as well as in carcinomas of the

132 he inhibitors decreased the proliferation of cervix cancer cells, while growth of primary normal kera

133 ons and exhibit antiproliferative effects on cervix cancer cells.

134 Human cervix cancer is caused by high-risk human papillomaviru

135 fe Questionnaire Core 30 (EORTC QLQ-C30) the cervix cancer module and chemotherapy and neuropathy sub

136 ode identification in patients with invasive cervix cancer undergoing radical hysterectomy and pelvic

137 Patients with locally advanced cervix cancer were randomly assigned to CIS chemoradioth

138 VAC) or topotecan plus cisplatin in advanced cervix cancer, we undertook a randomized trial comparing

139 splatin was the drug of choice in metastatic cervix cancer.

140 ant treatment failure still seen in advanced cervix cancer.

141 be an important prognostic tool in advanced cervix cancer.

142 hemotherapy over cisplatin alone in advanced cervix cancer.

143 microbe itself, as in Burkitt's lymphoma and cervix cancer.

144 may not have a role in assessing hypoxia in cervix cancer.

145 (CIS) chemoradiotherapy in locally advanced cervix cancer.

146 is the standard of care for locally advanced cervix cancer; the optimal chemotherapy regimen is not y

147 risks of stomach, female breast, and uterine cervix cancers persisted for 25 years, an apparent decre

148 d HPV45 account for approximately 20% of all cervix cancers.

149 sidered unrelated to treatment) and placebo (cervix carcinoma and colon adenoma) groups.

150 ve in the cytotoxicity assay using the human cervix carcinoma cell line KB-3-1 and its multidrug-resi

151 human prostate cancer cells but not in HeLa cervix carcinoma cells.

152 /necrosis ratio in breast adenocarcinoma and cervix carcinoma cells.

153 on, an increase in lipid levels, and in situ cervix carcinoma treated by conization.

154 established A431 epidermoid carcinoma, C33a cervix carcinoma, and LS174T colorectal adenocarcinoma.

155 er TNF-alpha and IL-1beta in T cell, B cell, cervix carcinoma, hepatoma, breast cancer, and astrocyto

156 erapy for advanced, recurrent, or metastatic cervix carcinoma.

157 stent infection in high-passage-number human cervix cells (HeLa-H cells; passages 170 to 221) but not

158 to 221) but not in low-passage-number human cervix cells (HeLa-L cells; passages 95 to 115) or in se

159 e compared samples from three groups: normal cervix, CIN 2/3 from immunocompetent women (HIV- CIN 2/3

160 significantly alters the biochemistry of the cervix, compared with women who have not had treatment;

161 Western-blotting on mouse cervix confirmed large scale histone de-acetylation in l

162 mphoma (5.7%)--and in females--cancer of the cervix (constituting 23.3% of all cancers in females) an

163 an epithelial endometrium-derived HEC-1B and cervix-derived HeLa cells, seeded and polarized on colla

164 of a Shirodkar suture in women with a short cervix does not substantially reduce the risk of early p

165 the first time, that viral infection of the cervix during pregnancy reduces the capacity of the fema

166 w for maximal compliance and dilation of the cervix during the birth process.

167 T) (oviducts) in comparison to the lower GT (cervix) during infection, as shown in animal models.

168 s, larynx, lung, soft tissue, female breast, cervix, endometrial, prostate, testes, eye and orbit, br

169 ALT in carcinomas arising from the bladder, cervix, endometrium, esophagus, gallbladder, kidney, liv

170 esented for carcinomas of the anus, bladder, cervix, endometrium, ovary, penis, prostate, rectum, tes

171 s studied (stomach, biliary tract, pancreas, cervix, endometrium, prostate, kidney, bladder, and lymp

172 , A-431 epidermoid carcinoma cells, and HeLa cervix epitheloid carcinoma cells.

173 5 pretreatment (18)F-FDG PET images (breast, cervix, esophageal, head and neck, and lung cancer tumor

174 ngth varies amongst women, the percentage of cervix excised may correlate more accurately to risk tha

175 ion that localizes to the SC junction of the cervix, expresses a unique gene expression signature, an

176 oeae and a high-resolution photograph of the cervix for ectopy measurement were collected.

177 m samples obtained from different locations (cervix, fornix, outer vaginal canal) and by different me

178 erve as a cutoff value to distinguish normal cervix from CIN and from CIN to CC.

179 Serum progesterone profiles, myometrium and cervix function, and mitochondrial electron transport ch

180 characteristic features are empty uterus and cervix, gestational sac in the anterior part of lower ut

181 epithelium and underlying stroma from normal cervix, graded CINs, cancer, and patient-matched normal

182 igh-grade lesions and cancers of the uterine cervix harbor integrated HPV genomes expressing the E6 a

183 Survival rates for cancer of the uterine cervix have improved over the last 40 years largely beca

184 he development of cancers, especially of the cervix, have previously been reported to downregulate GJ

185 tic marker in a variety of tumors, including cervix, head/neck, sarcoma, non-small cell of the lung,

186 o investigate whether, in women with a short cervix identified by routine transvaginal scanning at 22

187 e anal canal in 148 women (47.6%) and in the cervix in 82 (26.4%).

188 nd tissue distensibility was observed in the cervix in both models.

189 It is recognized that a short cervix in mid-pregnancy is associated with an increased

190 We hypothesized that a long cervix in mid-pregnancy would be associated with an incr

191 e and cytokine parameters occur in the human cervix in response to the male partner's seminal fluid.

192 ous acquistion of FP/HW Raman signals of the cervix in vivo within 1 s.

193 infection, whereas prior coinfections in the cervix increased risk of a new cervical HPV infection.

194 maRIIb receptor in the epithelium lining the cervix initiate expression of genes that block recruitme

195 less of the stage of the estrous cycle after cervix injection with PRV; (2) in contrast, the number o

196 In maternal epithelial tissues (thyroid, cervix, intestine, and gallbladder), 14% to 60% of XY+ c

197 rom the epidermis, oropharynx, esophagus and cervix into genetically defined tumors in a human three-

198 The uterine cervix is a hormone-responsive tissue, and female hormon

199 apparent diffusion coefficient (ADC) of the cervix is associated with preterm delivery in asymptomat

200 The cervix is central to the female genital tract immune res

201 Because the uterine cervix is derived from the same Mullerian duct precursor

202 The proinflammatory cytokine milieu in the cervix is enhanced in pregnant women with bacterial vagi

203 analgesia initiated early in labor (when the cervix is less than 4.0 cm dilated) has been associated

204 The uterine cervix is the boundary structure between the uterus and

205 uamous epithelia of human esophagus, tonsil, cervix, larynx, and cornea.

206 progression in an analysis of primary normal cervix, low grade squamous intraepithelial lesions, high

207 cervical tissue specimens, including normal cervix, low-grade squamous intraepithelial lesions (LSIL

208 onal age, 26 weeks) with a sonographic short cervix (</=15 mm) underwent pelvic 1.5-T magnetic resona

209 d in at least six distinct cancers: bladder, cervix, lung (adenocarcinoma and squamous cell carcinoma

210 is in human cancers including breast, colon, cervix, lung and pancreas.

211 er cell lines (from prostate, brain, kidney, cervix, lung, colon, liver, and breast tumors).

212 Altered local levels in the cervix may influence an individual's immune response, th

213 HIV-susceptible CD4(+) T cell subsets in the cervix may provide a mechanism for the increased HIV sus

214 a double-stranded DNA tumor virus infecting cervix, mouth, and throat tissues.

215 lysis to characterize immune cells in normal cervix (N = 21), HIV-negative high-grade dysplasia (N =

216 ervention, women destined to develop a short cervix (n = 36) exhibited higher cervico-vaginal concent

217 CSF-1 in cervical tumor (n = 17) and normal cervix (n = 8) samples.

218 nancies (n=642) and carcinoma of the uterine cervix (n=336).

219 malignancies (1.6%) were found: vulva (n=6), cervix (n=5), and anus (n=5).

220 be detected in the vulva/vagina than in the cervix (odds ratio, 4.38 [95% confidence interval, 2.51-

221 on a comparative transcriptomic study of the cervix of four placental mammals, mouse, guinea pig, rab

222 grade dysplasia and cancer that arose in the cervix of K14E6/E7 transgenic mice treated long-term wit

223 was induced by placing ligatures around the cervix of the maxillary second molars for 21 days.

224 lized nylon (000) thread ligature around the cervix of the second left upper molar of the animals, wh

225 of concordant incident HPV infections of the cervix or anus following infection at the other anatomic

226 AUS$35.99 (80% UI 28.47-41.18) with Policy1-Cervix or AUS$22.74 (15.49-34.45) with HPV-ADVISE, at a

227 rradiated region) abnormal FDG uptake in the cervix or lymph nodes in 20 patients.

228 and a traditional sample (obtained from the cervix or urethra), and used an appropriate reference st

229 test samples are obtained directly from the cervix or urethra.

230 ained on samples collected directly from the cervix or urethra.

231 fection characterized by inflammation of the cervix or urethra.

232 ts with squamous cell carcinoma (SCC) of the cervix or vulva have limited therapeutic options, and th

233 terectomy and hysterectomies that spared the cervix or were performed for cervical neoplasia, we esti

234 .1; 95% CI, 6.5-168), HSV isolation from the cervix (OR, 32.6; 95% CI, 4.1-260), HSV-1 vs HSV-2 isola

235 d been in cycling rats in proestrus (uterus, cervix) or diestrus (colon); OVX+E2 did not restore the

236 colon, rectum, liver, lung, breast (women), cervix, ovary, and prostate in adults, and adult and chi

237 t patients with small-cell carcinomas of the cervix, ovary, uterus, vagina, and vulva.

238 anoma, and 64 pelvic malignancies (prostate, cervix, penis, vulva).

239 malies and aneuploidy; examining the uterus, cervix, placenta, and amniotic fluid; and guiding obstet

240 ull mouse, and clearly demonstrated that the cervix plays a key role in their delayed parturition.

241 rachomatis and N. gonorrhoeae, respectively, cervix plus urine, 86 and 49%; cervix plus vagina, 91 an

242 respectively, cervix plus urine, 86 and 49%; cervix plus vagina, 91 and 93%; and vagina plus urine, 9

243 including in situ carcinomas of the uterine cervix, prostate, and female breast.

244 (CTL) cell lines and clones from the blood, cervix, rectum, and semen of 12 HIV-1-infected individua

245 nclear whether a pessary inserted around the cervix reduces the risk of preterm singleton birth.

246 dation statement applies to women who have a cervix, regardless of sexual history.

247 linical implications of these viruses at the cervix remain to be determined.

248 Carcinoma of the cervix remains a significant health problem for women wo

249 The cervix represents a formidable structural barrier for su

250 studying processes such as wound healing and cervix ripening.

251 01) in the SCCs relative to HSILs and normal cervix samples.

252 for advanced squamous cell carcinomas of the cervix, SCCA1 has also been found to be associated with

253 If the cervix shortened (<25 mm) before 24 weeks' gestation, wo

254 Squamous carcinomas of the cervix, skin, esophagus, and head and neck exhibited the

255 dually had similar infection kinetics in the cervix, SP6, the virulent variant, could be isolated fro

256 prominent path for lactate uptake by a human cervix squamous carcinoma cell line that preferentially

257 participants from 3 large US and Costa Rican cervix studies were typed for HLA class I alleles.

258 sessment of Cancer Therapy-General (FACT-G), Cervix subscale (Cx subscale), FACT/GOG-Neurotoxicity su

259 mber of viral target cells in the vagina and cervix, suggesting that the ratio of target cells to ant

260 1,453 msec +/- 123; T2, 59 msec +/- 1), and cervix (T1, 1,616 msec +/- 61; T2, 83 msec +/- 7).

261 etically engineered mice that express in the cervix the HPV16 early region genes implicated as causat

262 At term, fetal membranes overlying the cervix, the future site of rupture, show altered morphol

263 mor's origin to either the uterine corpus or cervix, the odds of the tumor originating from that site

264 quency of activated HIV targets cells at the cervix, the site of initial HIV entry in most women, pro

265 n epithelial cells of primitive neurons, the cervix, the vagina, and the endometrium in 5- to 400-fol

266 c HPV infection, compared with WNH without a cervix, they have minimal risk of HPV-induced cancer and

267 ted in advanced nonsquamous carcinoma of the cervix to determine its activity in patients who had fai

268 due to differences in susceptibility of the cervix to infection by virus during pregnancy and the as

269 induced in the physiological response of the cervix to seminal fluid in vivo.

270 tissues, we compared viruses from across the cervix to those in peripheral blood mononuclear cells (P

271 the Functional Assessment of Cancer Therapy-Cervix Trial Outcome Index (FACT-Cx TOI).

272 trophoblast retrieval and isolation from the cervix (TRIC).

273 Immediately before parturition the cervix undergoes striking changes in structure (ripening

274 rvical cancer, the malignant neoplasm of the cervix uteri is the second most common cancer among wome

275 ncluding those of the bladder, pancreas, and cervix uteri.

276 detected in the blood, lymph nodes, vagina, cervix, uterus, and fallopian tubes.

277 Epithelial cells from the cervix, uterus, and horns of the uterus were isolated, c

278 nostic factor in small-cell carcinoma of the cervix, uterus, and ovary.

279 otype-specific concordance suggests that the cervix (vagina) and anus may serve as reservoirs for HPV

280 Following analysis of primary cervix, vagina, and first-void female urine specimens fo

281 ts among single specimens, with the combined cervix-vagina results identifying the highest number of

282 d a striking homeotic transformation towards cervix/vagina, where Hoxa13 is normally expressed.

283 (especially type 16) can cause cancer of the cervix, vulva, vagina, anus, penis, and oropharynx.

284 The cervix was 15 mm or less in 470, and 253 (54%) of these

285 a diagnosis of adenocarcinoma of the uterine cervix was subjected to chemotherapy after radical surge

286 Policy1-Cervix was used to estimate the lifetime risk of cervica

287 esults and the presence of EBV or CMV in the cervix, we did find a high prevalence of both viruses: 2

288 y 26 of the 35 HPV types found to infect the cervix were also found within the oral cavity, and the t

289 or recurrent squamous cell carcinoma of the cervix were entered onto this study.

290 nd Obstetrics stage I or II carcinoma of the cervix were reviewed for information about patient chara

291 ntially found in the lower tract (vagina and cervix), whereas APCs and innate lymphoid cells were mai

292 re protected from ascending infection by the cervix, which controls and limits microbial access by th

293 uamous intraepithelial lesions (HSIL) of the cervix will progress to invasive squamous cell carcinoma

294 egies incorporating visual inspection of the cervix with acetic acid or DNA testing for HPV in one or

295 strategy involving visual inspection of the cervix with acetic acid or DNA testing for human papillo

296 approach combining visual inspection of the cervix with acetic acid wash (VIA) and cryotherapy.

297 We inoculated 45 female macaques in the cervix with Chlamydia trachomatis once weekly for 5 week

298 ked inflammatory cervical infiltrates in the cervix with enrichment of HIV target cells.

299 among women with a previous infection at the cervix with HPV of the same genotype.

300 or recurrent or persistent carcinoma of the cervix with measurable disease and GOG performance statu

301 tongue, esophagus, forestomach, and uterine cervix within just 10 to 20 days.